Artificial Intelligence

A French biotech is advancing a novel class of drugs that don't just fight cravings but may reverse the deep-seated brain changes caused by addiction.

HOMELINK names 25-year industry veteran Jeff Brock as VP of Account Management, signaling a strategic push to deepen client partnerships in a complex market.

Asset management giant Bitwise is launching professionally managed DeFi vaults, aiming to bring institutional capital to the world of onchain stablecoin yield.

Endocrinologist Dr. Eiriny Eskander's Caloria app uses photo-based AI to help users on Ozempic, or with PCOS, track food beyond the scale.

A strategic investment from Krieger Capital will fuel Global Key Solutions' AI platform, which transforms complex regulatory data into actionable safety insights.

Acumatica's 2026 Summit showcases practical AI tools, strategic acquisitions, and a major push to embed financial automation directly into its ERP.

With new President and CTO appointments, Hermeus signals a major shift from R&D to full-scale production of its high-Mach aircraft for defense.

A new report details a dramatic rise in ransomware and supply chain attacks, turning digital threats into life-or-death crises for the global health sector.

A new study reveals albumin, the most abundant protein in blood, is a powerful weapon against mucormycosis, offering new hope for treating this fatal infection.

The Autism Community in Action appoints Manny Khoshbin and Ross Mitchell, signaling a strategic push for national growth and the ethical use of AI.

The strategic acquisition unites AI design with sequencing analytics, creating an end-to-end platform poised to accelerate RNA therapeutic development.

Sprott Physical Uranium Trust can now raise another $1 billion to buy physical uranium, tightening its grip on a market already facing supply shortages.

As Yiwu prepares for the 2026 Spring Festival Gala, the global trade hub showcases how its powerful logistics and e-commerce engine fuels the world's festivities.

As AI and algorithms reshape our world, the National Cybersecurity Alliance offers expert guidance to help you protect your personal data and digital footprint.

A new AI platform from Eurofins CDMO Alphora predicts optimal drug forms, promising to cut costs and accelerate the path from lab to patient.

The AI platform just secured Series A funding to scale its solution that cuts corporate IP legal spend by 50% and accelerates patent filings to under 24 hours.

A new study confirms AI can detect major heart conditions from one brief ultrasound clip, empowering any clinician to perform life-saving cardiac screening.

Global insurer Starr partners with Five Sigma, adopting its AI-native platform and Clive™ expert agent to transform specialty claims and set a new industry blueprint.

Neurocrine Biosciences begins a Phase 2 trial for a new tardive dyskinesia drug, aiming to build on its market dominance and offer new hope for patients.

MACOM promotes key executives, signaling a dual focus on strategic acquisitions and pioneering Gallium Nitride semiconductor technology.